Convergence Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2024
         Q4  | $441K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | $243K | Sell | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $260K | Sell | 
         | 
    |||||
| 
        
          
      
        2024
         Q1  | $546K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q4  | $471K | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q3  | $459K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q2  | $277K | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q1  | $472K | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $509K | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $512K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $371K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $312K | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $326K | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q2  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2018
         Q1  | $2.43M | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q4  | $2.01M | Sell | 
         | 
    |||||
| 
        
          
      
        2017
         Q3  | $2.12M | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q2  | $1.43M | Buy | 
         |